133 related articles for article (PubMed ID: 27171122)
1. APOA5 and APOA1 polymorphisms are associated with triglyceride levels in Mexican children.
Suárez-Sánchez F; Klunder-Klunder M; Valladares-Salgado A; Gómez-Zamudio J; Peralta-Romero J; Meyre D; Burguete-García A; Cruz M
Pediatr Obes; 2017 Aug; 12(4):330-336. PubMed ID: 27171122
[TBL] [Abstract][Full Text] [Related]
2. Alcohol, Carbohydrate, and Calcium Intakes and Smoking Interactions with APOA5 rs662799 and rs2266788 were Associated with Elevated Plasma Triglyceride Concentrations in a Cross-Sectional Study of Korean Adults.
Park S; Kang S
J Acad Nutr Diet; 2020 Aug; 120(8):1318-1329.e1. PubMed ID: 32335043
[TBL] [Abstract][Full Text] [Related]
3. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
4. Association of rs662799 and rs5070 genetic polymorphisms with hypertriglyceridemia and atherogenic dyslipidemia in pediatric patients in Southeast Mexico.
Ovando Gómez V; Zavaleta Muñiz SA; Ochoa-Díaz-López H; Hernández Contreras JAC; Irecta Nájera CA
Clin Investig Arterioscler; 2023; 35(2):53-63. PubMed ID: 35961839
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents.
Zhu WF; Wang CL; Liang L; Shen Z; Fu JF; Liu PN; Lv LQ; Zhu YM
Lipids Health Dis; 2014 Jun; 13():93. PubMed ID: 24903888
[TBL] [Abstract][Full Text] [Related]
6. Association of apolipoprotein A1 and A5 polymorphisms with stroke subtypes in Han Chinese people in Taiwan.
Hsu LC; Hsu LS; Lee TH
Gene; 2019 Feb; 684():76-81. PubMed ID: 30367981
[TBL] [Abstract][Full Text] [Related]
7. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
[TBL] [Abstract][Full Text] [Related]
8. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
You Y; Wu YH; Zhang Y; Zhang L; Song Y; Bai W; Li Y; Yu Y; Kou C
BMJ Open; 2018 Jun; 8(6):e020016. PubMed ID: 29866721
[TBL] [Abstract][Full Text] [Related]
9. ACE, APOA5, and MTP Gene Polymorphisms Analysis in Relation to Triglyceride and Insulin Levels in Pediatric Patients.
Carranza-González L; León-Cachón RBR; González-Zavala MA; Ríos-Ibarra C; Morlett-Chávez J; Sánchez-Domínguez C; Cepeda-Nieto A; Salinas-Santander M
Arch Med Res; 2018 Feb; 49(2):94-100. PubMed ID: 29705673
[TBL] [Abstract][Full Text] [Related]
10. The APOA5-rs662799 Polymorphism Is a Determinant of Dyslipidemia in Vietnamese Primary School Children.
Hanh NTH; Nhung BT; Hop LT; Tuyet LT; Dao DTA; Thu NTT; Binh TQ
Lipids; 2020 Nov; 55(6):683-691. PubMed ID: 32777089
[TBL] [Abstract][Full Text] [Related]
11. Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes.
Vrablik M; Hubacek JA; Dlouha D; Satny M; Adamkova V; Ceska R
Folia Biol (Praha); 2019; 65(4):188-194. PubMed ID: 31903892
[TBL] [Abstract][Full Text] [Related]
12. APOA5 Variant rs662799, Role in Cardiovascular Traits and Serum Adipokine Levels in Caucasian Obese Subjects.
de Luis DA; Izaola O; Primo D; Aller R
Ann Nutr Metab; 2021; 77(5):299-306. PubMed ID: 34350864
[TBL] [Abstract][Full Text] [Related]
13. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.
Chien KL; Fang WH; Wen HC; Lin HP; Lin YL; Lin SW; Wu JH; Kao JT
Clin Chim Acta; 2008 Apr; 390(1-2):56-62. PubMed ID: 18206649
[TBL] [Abstract][Full Text] [Related]
14. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia.
De Castro-Orós I; Cenarro A; Tejedor MT; Baila-Rueda L; Mateo-Gallego R; Lamiquiz-Moneo I; Pocoví M; Civeira F
Circ Cardiovasc Genet; 2014 Dec; 7(6):814-21. PubMed ID: 25176936
[TBL] [Abstract][Full Text] [Related]
15. Association of apolipoprotein A5 gene polymorphisms and serum lipid levels.
Li YY; Yin RX; Lai CQ; Li M; Long XJ; Li KL; Liu WY; Zhang L; Wu JZ
Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):947-56. PubMed ID: 20708914
[TBL] [Abstract][Full Text] [Related]
16. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
[TBL] [Abstract][Full Text] [Related]
17. Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
Hong CJ; Chen TT; Bai YM; Liou YJ; Tsai SJ
World J Biol Psychiatry; 2012 Jan; 13(1):22-9. PubMed ID: 21375366
[TBL] [Abstract][Full Text] [Related]
18. Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy.
Bautista-Martínez JS; Mata-Marín JA; Sandoval-Ramírez JL; Chaparro-Sánchez A; Manjarrez-Téllez B; Uribe-Noguez LA; Gaytán-Martínez J; Núñez-Armendáriz M; Cruz-Sánchez A; Núñez-Rodríguez N; Iván MA; Morales-González GS; Álvarez-Mendoza JP; Pérez-Barragán E; Ríos-De Los Ríos J; Contreras-Chávez GG; Tapia-Magallanes DM; Ribas-Aparicio RM; Díaz-López M; Olivares-Labastida A; Gómez-Delgado A; Torres J; Miranda-Duarte A; Zenteno JC; Pompa-Mera EN
Pharmacogenet Genomics; 2022 Apr; 32(3):101-110. PubMed ID: 34693928
[TBL] [Abstract][Full Text] [Related]
19. The Association Between APOA5 Gene Polymorphisms and Plasma Lipids in the Turkish Cypriot Population: A Possible Biomarker for Preventing Cardiovascular Diseases.
Fahrioğlu U; Ergören MÇ
Biochem Genet; 2018 Jun; 56(3):176-187. PubMed ID: 29264753
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease.
Xu Y; Lu LL; Liu SS; Du SX; Zhu HL; Dong QJ; Xin YN
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):214-219. PubMed ID: 29735301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]